| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8725218 | Clinical Gastroenterology and Hepatology | 2018 | 30 Pages |
Abstract
In this retrospective study of patients with AIH who received mycophenolate mofetil as a rescue therapy, we found the drug to be well tolerated and moderately effective, inducing biochemical remission in 60% of subjects. Rates of response are lower and rates of infection are higher in patients with AIH and cirrhosis. Prospective studies of mycophenolate mofetil are warranted for this population.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Stuart K. Roberts, Ricky Lim, Simone Strasser, Amanda Nicoll, Alessia Gazzola, Joanne Mitchell, Way Siow, Tiffany Khoo, Zaki Hamarneh, Martin Weltman, Paul Gow, Natasha Janko, Edmund Tse, Gauri Mishra, En-Hsiang Cheng, Miriam Levy, Wendy Cheng,